Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02XYA
|
||||
Former ID |
DNCL002769
|
||||
Drug Name |
Astuprotimut-R
|
||||
Indication | Adjuvant non-small-cell lung carcinoma; Melanoma [ICD9: 162, 172; ICD10:C33, C34, C43] | Phase 3 | [522494] | ||
Company |
GlaxoSmithKline
|
||||
Target and Pathway | |||||
Target(s) | Melanoma-associated antigen 3 | Target Info | Modulator | [550432] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.